Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 


Malaghan Institute Finalist in the Wellington Gold Awards

Malaghan Institute Finalist in the Wellington Gold Awards


The Malaghan Institute of Medical Research is a finalist in the Wellington Gold Awards (Cyber Gold category).

Established in 1999, the annual Gold Awards are a showcase of organisational talent and capability and are a way of paying tribute to those who are building our community.

The Malaghan Institute’s Director, Professor Graham Le Gros says, “We’re delighted. This recognition validates all of our hard work to find better treatments for diseases like cancer and asthma and it reinforces our role in harnessing cutting edge technology to help beat diseases sooner.”

The Cyber Gold Award recognises innovation, leadership and sustained growth in the information sector.

The Malaghan Institute is New Zealand’s leading independent medical research institute. The Institute is focused on improving the quality of life of New Zealanders by harnessing the power of the immune system; the body’s own natural defence against disease.

Professor Graham Le Gros says, “We’ve been part of Wellington for almost 50 years and our goal has remained constant, to develop better treatments for people with diseases like cancer, asthma and allergic diseases. Like the Gold Awards, we’ve grown in reputation and outcomes. But this award is not about us. Patients need better solutions, fast. That's what we're aiming for.

“Modern medicine and technology are inseparable. The story of medical progress at the Malaghan Institute is one of excellence in technology. We use world–leading techniques like laser analysis of cells using Flow Cytometry to help accelerate the pace of our research.

“Our combination of knowledge, experience and technology creates the platform for success. In 2013 our achievements included the discovery of a unique type of immune cell in the skin, which impacts the development of allergic skin disease; the start of our Phase 1 clinical trial of a melanoma cancer immunotherapy and being part of global Cancer Immunotherapy effort recently recognised by the internationally renowned journal Science as the worldwide Scientific Breakthrough of 2013.

“We are particularly delighted to be recognised by the Gold Awards as it helps us demonstrate to our thousands of supporters throughout New Zealand that their generosity will help us beat diseases sooner. Medical research is challenging, but thanks to the support of people and organisations throughout New Zealand this is an era of great promise for immunotherapy."

Ends

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Media: Julian Wilcox Leaves Māori TV

Māori Television has confirmed the resignation of Head of News and Production Julian Wilcox. Mr Maxwell acknowledged Mr Wilcox’s significant contribution to Māori Television since joining the organisation in 2004. More>>

ALSO:

Genetics: New Heat Tolerant Cow Developed

Hamilton, New Zealand-based Dairy Solutionz Ltd has led an expert genetics team to develop a new dairy cow breed conditioned to thrive in lower elevation tropical climates and achieve high milk production under heat stress. More>>

Fractals: Thousands More Business Cards Needed To Build Giant Sponge

New Zealand is taking part in a global event this weekend to build a Menger Sponge using 15 million business cards but local organisers say they are thousands of business cards short. More>>

Scoop Business: NZ Net Migration Rises To Annual Record In September

New Zealand’s annual net migration rose to a record in September, beating government forecasts, as the inflow was spurred by student arrivals from India and Kiwis returning home from Australia. More>>

ALSO:

Scoop Business: Fletcher To Close Its Christchurch Insulation Plant, Cut 29 Jobs

Fletcher Building, New Zealand’s largest listed company, will close its Christchurch insulation factory, as it consolidates its Tasman Insulations operations in a “highly competitive market”. More>>

ALSO:

Scoop Business: Novartis Adds Nine New Treatments Under Pharmac Deal

Novartis New Zealand, the local unit of the global pharmaceuticals firm, has added nine new treatments in a far-ranging agreement with government drug buying agency, Pharmac. More>>

ALSO:

Crown Accounts: English Wary On Tax Take, Could Threaten Surplus

Finance Minister Bill English is warning the tax take may come in below forecast in the current financial year, as figures released today confirm it was short by nearly $1 billion in the year to June 30 and English warned of the potential impact of slumping receipts from agricultural exports. More>>

ALSO:

Auckland Outage: Power Mostly Restored Overnight

Vector wishes to advise that all but 324 customers have been restored overnight. These customers are spread throughout the network in small pockets. The main St Johns feeder was restored around midnight allowing most of the customers in all affected areas to have power this morning. More>>

ALSO:

Get More From Scoop

 
 
Standards New Zealand

Standards New Zealand

Mosh Social Media
 
 
 
 
 
 
 
 
Sci-Tech
Search Scoop  
 
 
Powered by Vodafone
NZ independent news